本文關(guān)鍵詞：益君康聯(lián)合艾灸治療腹瀉型腸易激綜合征的臨床觀察　出處：《山東中醫(yī)藥大學(xué)》2016年碩士論文　論文類型：學(xué)位論文

  更多相關(guān)文章： 腸易激綜合征 艾灸 益君康 臨床觀察

【摘要】：目的:通過對益君康聯(lián)合艾灸治療腹瀉型腸易激綜合征的臨床觀察,分析其療效及安全性,為采用此方案治療腹瀉型腸易激綜合征提供資料,更好的指導(dǎo)臨床治療用藥。方法:符合納入標(biāo)準(zhǔn)的腹瀉型腸易激綜合征患者70例隨機分成兩組,治療組和對照組各35例。對照組給予黃連素治療;治療組給予益君康加艾灸聯(lián)合治療。觀察和記錄兩組患者治療前后的癥狀積分變化、不良反應(yīng)的類型、程度、發(fā)生率以及復(fù)發(fā)率。結(jié)果:66例完成治療與復(fù)查。治療組與對照組總有效率分別為87.88%和66.67%,顯效率分別為60.61%和33.33%,兩組患者總有效率和顯效率比較均有統(tǒng)計學(xué)差異(P㩳0.05);在改善腹痛或腹部不適程度及頻率、大便次數(shù)、大便性狀、里急后重等癥狀積分方面治療組明顯優(yōu)于對照組。兩組治療期間均未出現(xiàn)明顯不良反應(yīng)。停藥4周后隨訪,治療組共20例治愈及顯效的患者中有4例(20.00%)復(fù)發(fā)或加重,對照組11例治愈及顯效患者中有6例(54.55%)復(fù)發(fā)或加重,兩組復(fù)發(fā)率比較,沒有統(tǒng)計學(xué)差異(P㧐0.05)。結(jié)論:益君康聯(lián)合艾灸在治療腹瀉型腸易激綜合征方面療效更好且不良反應(yīng)少。
[Abstract]:Objective: to observe the efficacy and safety of Yijun Kang combined with moxibustion in the treatment of diarrhea irritable bowel syndrome, and to provide data for the treatment of diarrhea irritable bowel syndrome. Methods: 70 patients with diarrhea irritable bowel syndrome were randomly divided into two groups: treatment group (n = 35) and control group (n = 35). The treatment group was treated with Yijun Kang plus moxibustion. Observe and record the change of symptom integral, the type and degree of adverse reaction before and after treatment. Results the total effective rates of treatment group and control group were 87.88% and 66.67% respectively. The effective rates were 60.61% and 33.33, respectively. There were significant differences in the total effective rate and the effective rate between the two groups. 0.05; In improving abdominal pain or abdominal discomfort degree and frequency, defecation frequency, stool traits. The treatment group was significantly better than the control group in terms of the score of severe and severe symptoms. There were no significant adverse reactions during the treatment in both groups. 4 weeks after withdrawal of the drug, the patients in the treatment group were followed up. In the treatment group, there were 4 cases of recurrence or aggravation of 20 cases of cure and remarkable effect, and 6 cases of the control group of 11 cases of cure and remarkable effect) recurrence or aggravation. There was no statistical difference in the recurrence rate between the two groups. Conclusion: Yijun Kanglian combined moxibustion is more effective and less adverse in treating diarrhea irritable bowel syndrome.
【學(xué)位授予單位】：山東中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2016
【分類號】：R259

【參考文獻】

相關(guān)期刊論文 前10條

1 羅哲;崔立紅;賀星;;腸道菌群失調(diào)與腸易激綜合征關(guān)系的研究進展[J];解放軍醫(yī)學(xué)院學(xué)報;2015年10期

2 齊英娜;張聲生;;張聲生教授論治腹瀉型腸易激綜合征經(jīng)驗[J];中華中醫(yī)藥雜志;2015年08期

3 吳淑娟;潘建春;;腸易激綜合征發(fā)病機制研究進展[J];溫州醫(yī)科大學(xué)學(xué)報;2015年05期

4 吳皓萌;敖海清;徐志偉;史亞飛;黎穎賢;胡海燕;吉云鵬;張晨;袁玉梅;;腹瀉型腸易激綜合征中醫(yī)證候與外周敏化關(guān)系的研究[J];中華中醫(yī)藥雜志;2015年05期

5 凌萌智;;匹維溴銨治療腹瀉型腸易激綜合征療效觀察[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2015年02期

6 沈月霖;;復(fù)方嗜酸乳桿菌片聯(lián)合馬來酸曲美布汀治療腸易激綜合征71例療效觀察[J];中國現(xiàn)代藥物應(yīng)用;2015年01期

7 謝龍;;洛哌丁胺聯(lián)合黛力新治療腹瀉型腸易激綜合征的療效觀察[J];吉林醫(yī)學(xué);2015年01期

8 陳宏;康密;;艾灸配合中成藥治療腹瀉型腸易激綜合征38例[J];陜西中醫(yī)學(xué)院學(xué)報;2014年06期

9 邵宗利;杜柏;陳翰明;費英俊;;腸易激綜合征的辨證論治[J];中國療養(yǎng)醫(yī)學(xué);2014年04期

10 賀星;崔立紅;王曉輝;閆志輝;李超;弓三東;;飲食習(xí)慣與腸易激綜合征相關(guān)性調(diào)查[J];解放軍醫(yī)藥雜志;2014年02期

，

本文編號：1372975